These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36524893)

  • 1. Changes in endemic patterns of respiratory syncytial virus infection in pediatric patients under the pressure of nonpharmaceutical interventions for COVID-19 in Beijing, China.
    Jiang ML; Xu YP; Wu H; Zhu RN; Sun Y; Chen DM; Wang F; Zhou YT; Guo Q; Wu A; Qian Y; Zhou HY; Zhao LQ
    J Med Virol; 2023 Jan; 95(1):e28411. PubMed ID: 36524893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changed endemic pattern of human adenovirus from species B to C among pediatric patients under the pressure of non-pharmaceutical interventions against COVID-19 in Beijing, China.
    Wang F; Zhu R; Qian Y; Sun Y; Chen D; Wang F; Zhou Y; Guo Q; Liu L; Xu Y; Cao L; Qu D; Zhao L
    Virol J; 2023 Jan; 20(1):4. PubMed ID: 36624458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological characteristics of respiratory viruses in hospitalized children during the COVID-19 pandemic in southwestern China.
    Zhu L; Luo T; Yuan Y; Yang S; Niu C; Gong T; Wang X; Xie X; Luo J; Liu E; Fu Z; Tian D
    Front Cell Infect Microbiol; 2023; 13():1142199. PubMed ID: 37153160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surveillance for respiratory syncytial virus subtypes A and B in children with acute respiratory infections in Beijing during 2000 to 2006 seasons].
    Deng J; Qian Y; Zhu RN; Wang F; Zhao LQ
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):924-7. PubMed ID: 17254462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiological and clinical characteristics of respiratory syncytial virus infection among people aged 60 and above in Beijing City].
    Wei XF; Li MZ; Wang YT; Huang Q; Gong C; Suo LD; Huang F
    Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Jul; 58(7):952-958. PubMed ID: 39034779
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of infections with respiratory syncytial virus between children and adults: a multicenter surveillance from 2015 to 2019 in Beijing, China.
    Luo M; Gong C; Zhang Y; Wang X; Liu Y; Luo Q; Li M; Li A; Wang Y; Dong M; Xu W; Huang F
    Eur J Clin Microbiol Infect Dis; 2022 Dec; 41(12):1387-1397. PubMed ID: 36197575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of COVID-19 Nonpharmaceutical Interventions on Respiratory Syncytial Virus Infections in Hospitalized Children.
    Lu Y; Chen Q; Ren S; Zhang Y; Yi L; Qian C; Shen J; Liu X; Jiang M; Wang B; Song J; Shao X; Zhang T; Tian J; Zhao G
    Influenza Other Respir Viruses; 2024 Apr; 18(4):e13291. PubMed ID: 38653953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory Syncytial Virus Seasonality, Beijing, China, 2007-2015.
    Yu J; Liu C; Xiao Y; Xiang Z; Zhou H; Chen L; Shen K; Xie Z; Ren L; Wang J
    Emerg Infect Dis; 2019 Jun; 25(6):1127-1135. PubMed ID: 31107230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiologic characteristics and the relationship with disease severity of respiratory syncytial virus genotypes from children with lower respiratory tract infection in the southern Zhejiang province].
    Dong L; Dai L; Fan J; Chen X; Jin X; Zhang Y; Lin H
    Zhonghua Er Ke Za Zhi; 2015 Jul; 53(7):537-41. PubMed ID: 26310648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular biological and clinical characteristics of respiratory syncytial virus in children with bronchiolitis].
    Zhang TH; Deng J; Qian Y; Zhu RN; Sun Y; Wang F; Tian R; Zhao LQ
    Zhonghua Er Ke Za Zhi; 2017 Aug; 55(8):586-592. PubMed ID: 28822433
    [No Abstract]   [Full Text] [Related]  

  • 11. Human respiratory syncytial virus in children with lower respiratory tract infections or influenza-like illness and its co-infection characteristics with viruses and atypical bacteria in Hangzhou, China.
    Yu X; Kou Y; Xia D; Li J; Yang X; Zhou Y; He X
    J Clin Virol; 2015 Aug; 69():1-6. PubMed ID: 26209367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Nonpharmaceutical Interventions during the COVID-19 Pandemic on the Prevalence of Respiratory Syncytial Virus in Hospitalized Children with Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis.
    Leija-Martínez JJ; Esparza-Miranda LA; Rivera-Alfaro G; Noyola DE
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Nonpharmaceutical Interventions Implemented in Response to the COVID-19 Pandemic on Seasonal Respiratory Syncytial Virus: Analysis of Google Trends Data.
    Ravkin HD; Yom-Tov E; Nesher L
    J Med Internet Res; 2022 Dec; 24(12):e42781. PubMed ID: 36476385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological characteristics and phylogenic analysis of human respiratory syncytial virus in patients with respiratory infections during 2011-2016 in southern China.
    Luo HJ; Huang XB; Zhong HL; Ye CX; Tan X; Zhou K; Yuan L; Zhang SF; Zhu X; Lin CJ; Wang WJ; Xu L; Cao KY
    Int J Infect Dis; 2020 Jan; 90():5-17. PubMed ID: 31634614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Human Parainfluenza Virus Type 3 and Respiratory Syncytial Virus Infections in the Time of Coronavirus Disease 2019: Findings From a Household Cohort in Maryland.
    Hetrich MK; Oliva J; Wanionek K; Knoll MD; Lamore M; Esteban I; Veguilla V; Dawood FS; Karron RA;
    Clin Infect Dis; 2023 Apr; 76(8):1349-1357. PubMed ID: 36503986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential impact of COVID-19 non-pharmaceutical interventions on the epidemiological dynamics of respiratory syncytial virus subtypes A and B.
    Holmdahl I; Bents SJ; Baker RE; Casalegno JS; Trovão NS; Park SW; Metcalf JE; Viboud C; Grenfell B
    Sci Rep; 2024 Jun; 14(1):14527. PubMed ID: 38914626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-Depth Analysis of the Re-Emergence of Respiratory Syncytial Virus at a Tertiary Care Hospital in Germany in the Summer of 2021 after the Alleviation of Non-Pharmaceutical Interventions Due to the SARS-CoV-2 Pandemic.
    Hönemann M; Thiem S; Bergs S; Berthold T; Propach C; Siekmeyer M; Frille A; Wallborn T; Maier M; Pietsch C
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the impact of COVID-19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa.
    Bents SJ; Viboud C; Grenfell BT; Hogan AB; Tempia S; von Gottberg A; Moyes J; Walaza S; Hansen C; Cohen C; Baker RE
    Influenza Other Respir Viruses; 2023 Dec; 17(12):e13229. PubMed ID: 38090227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological and clinical characteristics of respiratory syncytial virus and influenza infections in hospitalized children before and during the COVID-19 pandemic in Central China.
    Ren L; Lin L; Zhang H; Wang Q; Cheng Y; Liu Q; Fang B; Xie L; Wang M; Yang J; Guo J; Zhang T; Lian H; Wang J; Yu H
    Influenza Other Respir Viruses; 2023 Feb; 17(2):e13103. PubMed ID: 36824393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Respiratory Syncytial Virus Genotypes and Genetic Variability of the G Gene during 2017 and 2018/2019 Seasonal Epidemics Isolated from Children with Lower Respiratory Tract Infections in Daejeon, Korea.
    Kang HM; Park KC; Park J; Kil HR; Yang EA
    J Korean Med Sci; 2020 Dec; 35(49):e422. PubMed ID: 33350185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.